Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 27
Filtrer
1.
Front Pharmacol ; 13: 692437, 2022.
Article de Anglais | MEDLINE | ID: mdl-35935877

RÉSUMÉ

We investigated the effect of increased pH induced by acid suppressants on the viability of non-Helicobacter pylori helicobacters (NHPHs) within parietal cell intracellular canaliculi and fundic glandular lumina by immunohistochemistry, electron microscopy, quantitative PCR, urea breath tests, and using a bilayer culture system. Three months before the experiment, mice were infected with the NHPH H. suis and then treated with famotidine (2 mg/kg body weight [BW], once daily), lansoprazole (30 mg/kg BW, once daily), or vonoprazan (20 mg/kg BW, once daily) for 3 days. Immunohistochemical studies using the TUNEL method, quantitative PCR analysis, and urea breath tests were performed. PCR analysis showed a decrease in the NHPH quantity after vonoprazan treatment. Urea breath tests revealed a significant decrease in the NHPH urease activity after vonoprazan, lansoprazole, and famotidine treatments for 3 days; however, 4 days after the treatment, urease activity reversed to the pretreatment level for each treatment group. Electron microscopy revealed an increase in the damaged NHPH after vonoprazan treatment. The TUNEL method revealed apoptotic NHPH within parietal cells after vonoprazan treatment. The bilayer culture results demonstrated that NHPH moved more quickly at a pH of 4.0 than at a pH of 3.0, 5.0, and 6.5, and electron microscopy revealed a change from the spiral form to the coccoid form under near-neutral pH conditions. We thus proposed that acid suppressants, especially vonoprazan, induce NHPH damage by altering pH.

2.
Front Pharmacol ; 12: 613458, 2021.
Article de Anglais | MEDLINE | ID: mdl-33897415

RÉSUMÉ

Naturally occurring isothiocyanates (ITCs) from edible vegetables have shown potential as chemopreventive agents against several types of cancer. The aims of the present study were to study the potential of ITCs in chemoprevention and in potentiating the efficacy of cytotoxic drugs in gastric cancer treatment. The chemoprevention was studied in chemically induced mouse model of gastric cancer, namely N-methyl-N-nitrosourea (MNU) in drinking water, and in a genetically engineered mouse model of gastric cancer (the so-called INS-GAS mice). The pharmacological effects of ITCs with or without cisplatin were studied in human gastric cell lines MKN45, AGS, MKN74 and KATO-III, which were derived from either intestinal or diffused types of gastric carcinoma. The results showed that dietary phenethyl isothiocyanate (PEITC) reduced the tumor size when PEITC was given simultaneously with MNU, but neither when administrated after MNU nor in INS-GAS mice. Treatments of gastric cancer cells with ITCs resulted in a time- and concentration-dependent inhibition on cell proliferation. Pretreatment of gastric cancer cells with ITCs enhanced the inhibitory effects of cisplatin (but not 5-fluorouracil) in time- and concentration-dependent manners. Treatments of gastric cancer cells with PEITC plus cisplatin simultaneously at different concentrations of either PEITC or cisplatin exhibited neither additive nor synergetic inhibitory effect. Furthermore, PEITC depleted glutathione and induced G2/M cell cycle arrest in gastric cancer cells. In conclusion, the results of the present study showed that PEITC displayed anti-cancer effects, particularly when given before the tumor initiation, suggesting a chemopreventive effect in gastric cancer, and that pretreatment of PEITC potentiated the anti-cancer effects of cisplatin, possibly by reducing the intracellular pool of glutathione, suggesting a possible combination strategy of chemotherapy with pretreatment with PEITC.

3.
iScience ; 24(2): 102091, 2021 Feb 19.
Article de Anglais | MEDLINE | ID: mdl-33598644

RÉSUMÉ

Tumors comprise cancer cells and the associated stromal and immune/inflammatory cells, i.e., tumor microenvironment (TME). Here, we identify a metabolic signature of human and mouse model of gastric cancer and show that vagotomy in the mouse model reverses the metabolic reprogramming, reflected by metabolic switch from glutaminolysis to OXPHOS/glycolysis and normalization of the energy metabolism in cancer cells and TME. We next identify and validate SNAP25, mTOR, PDP1/α-KGDH, and glutaminolysis as drug targets and accordingly propose a therapeutic strategy to target the nerve-cancer metabolism. We demonstrate the efficacy of nerve-cancer metabolism therapy by intratumoral injection of BoNT-A (SNAP25 inhibitor) with systemic administration of RAD001 and CPI-613 but not cytotoxic drugs on overall survival in mice and show the feasibility in patients. These findings point to the importance of neural signaling in modulating the tumor metabolism and provide a rational basis for clinical translation of the potential strategy for gastric cancer.

4.
Helicobacter ; 25(5): e12700, 2020 Oct.
Article de Anglais | MEDLINE | ID: mdl-32790220

RÉSUMÉ

BACKGROUND: The clinical significance of non-Helicobacter pylori Helicobacter (NHPH) is still unknown. There are many reports of NHPH-infected patients suffering from gastric diseases. Here, we investigated the polymerase chain reaction (PCR) positivity of NHPH infection in gastric disease patients who were negative for H. pylori (Hp) by the rapid urease test and by pathological observation. MATERIALS AND METHODS: We collected the 296 endoscopically obtained gastric mucosal samples of Hp-negative gastric disease patients diagnosed based on a rapid urease test and pathology from 17 hospitals in Japan from September 2013 to June 2019, and we analyzed the existence of Hp and NHPH by PCR. The samples were also treated by indirect immunohistochemistry using an anti-Helicobacter suis VacA paralog antibody and were observed by confocal laser microscopy. RESULTS: Among the 236 non-Hp-eradicated cases, 49 cases (20.8%) were positive for NHPH. Among them, 20 cases were positive for Helicobacter suis, 7 cases were positive for Helicobacter heilmannii sensu stricto/ Helicobacter ailurogastricus (Hhss/Ha), and the other 22 cases could not be identified. The regional differences in the infection rates were significant. Forty percent of the nodular gastritis cases, 24% of the MALT lymphoma, 17% of the chronic gastritis cases, and 33% of the gastroduodenal ulcer cases were NHPH positive. Forty-five patients had been treated with one of the four types of combinations of a proton pump inhibitor and two antibiotics, and in all of these cases, the NHPH diagnosed by PCR was successfully eradicated. Immunohistochemistry using the Helicobacter suis-specific HsvA antibody coincided well with the PCR results. Among the 29 post-Hp eradication cases, three were NHPH positive, including one Hhss/Ha-positive case. Thus, approx. 20% of the Hp-negative non-Hp-eradicated gastric disease patients treated at 17 hospitals in Japan were infected with NHPH.


Sujet(s)
Antibactériens , Muqueuse gastrique , Infections à Helicobacter , Helicobacter , Inhibiteurs de la pompe à protons , Maladies de l'estomac , Adulte , Sujet âgé , Antibactériens/pharmacologie , Antibactériens/usage thérapeutique , Association de médicaments , Femelle , Muqueuse gastrique/effets des médicaments et des substances chimiques , Muqueuse gastrique/microbiologie , Muqueuse gastrique/anatomopathologie , Helicobacter/classification , Helicobacter/effets des médicaments et des substances chimiques , Helicobacter/isolement et purification , Infections à Helicobacter/diagnostic , Infections à Helicobacter/épidémiologie , Infections à Helicobacter/thérapie , Humains , Immunohistochimie , Japon , Mâle , Adulte d'âge moyen , Réaction de polymérisation en chaîne , Prévalence , Inhibiteurs de la pompe à protons/pharmacologie , Inhibiteurs de la pompe à protons/usage thérapeutique , Maladies de l'estomac/diagnostic , Maladies de l'estomac/épidémiologie , Maladies de l'estomac/thérapie
5.
Curr Pharm Des ; 26(25): 3039-3045, 2020.
Article de Anglais | MEDLINE | ID: mdl-32329683

RÉSUMÉ

BACKGROUND: The hepatic and pulmonary MALT lymphoma (mucosa-associated lymphoid tissue lymphoma) is clinically occasionally observed but its pathogenesis is unknown and thought to be important to establish the treatment strategy. OBJECTIVES: The present study was designed to clarify the characteristics of these lymphomas and the effect of the Helicobacter eradication regimen and substance P antagonist. METHODS: After the long term infection of Helicobacter suis to the C57BL/6 mice stomach, the whole organ was surveyed pathologically. Histochemical characteristics of the lesion and the localization of bacteria were observed. In addition, the effect of the administration of antibiotics and a proton pump inhibitor or the substance P antagonist was investigated. RESULTS: We have detected the hepatic and pulmonary MALT lymphoma after the long term infection. In situ hybridization study revealed the positive reaction of Helicobacter suis in the hepatic and pulmonary MALT lymphoma. After the administration of antibiotics and a proton pump inhibitor, the bacterial number has significantly decreased and the tumor size in the fundus, liver and lung markedly reduced. Substance P immunoreactivity was clearly shown in the lymphoma cells in the liver and lung, and the spantide II administration induced the marked decrease in the size of tumors. CONCLUSION: By our experiments using the long term infection of Helicobacter suis to the C57BL/6 mice, we have detected the liver and pulmonary MALT lymphoma. In situ hybridization study suggested the direct interaction of this bacterium to the etiology of these lesions. Substance P within the lymphoma cells was suggested to work on the maintenance of the extragastric MALT lymphoma.


Sujet(s)
Infections à Helicobacter , Helicobacter heilmannii , Helicobacter pylori , Lymphome B de la zone marginale , Tumeurs de l'estomac , Animaux , Infections à Helicobacter/traitement médicamenteux , Foie , Poumon , Lymphome B de la zone marginale/traitement médicamenteux , Souris , Souris de lignée C57BL , Substance P
6.
Eur Urol Oncol ; 3(4): 530-539, 2020 08.
Article de Anglais | MEDLINE | ID: mdl-32037304

RÉSUMÉ

BACKGROUND: Patients with metastatic renal cell carcinoma (mRCC) may present with primary metastases (synchronous disease) or develop metastases during follow-up (metachronous disease). The impact of time to metastasis on patient outcome is poorly characterised. OBJECTIVE: To characterise overall survival (OS) and time to treatment failure (TTF) based on time to metastasis in mRCC patients treated with targeted therapy (tyrosine kinase inhibitors [TKIs]). DESIGN, SETTING, AND PARTICIPANTS: We used the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) to compare synchronous (metastases within ≤3 mo of initial diagnosis of cancer) versus metachronous disease (evaluated by >3-12 mo, >1-2 yr, >2-7 yr, and >7 yr intervals). OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: OS and TFF were assessed using Kaplan-Meier curves. Cox multivariable regressions analyses (MVAs) were adjusted for baseline factors. RESULTS AND LIMITATIONS: Of 7386 patients with mRCC treated with first-line TKIs, 3906 (53%) and 3480 (47%) had synchronous and metachronous metastasis, respectively. More patients with synchronous versus metachronous disease had higher T stage (T1-2: 19% vs 34%), N1 disease (21% vs 6%), presence of sarcomatoid differentiation (15.8% vs 7.9%), Karnofsky performance status <80 (25.9% vs 15.1%), anaemia (62.5% vs 42.3%), elevated neutrophils (18.9% vs 10.9%), elevated platelets (21.6% vs 11.4%), bone metastases (40.4% vs 29.8%), and IMDC poor risk (40.6% vs 11.3%). Synchronous versus metachronous disease by intervals >3-12 mo, >1-2 yr, >2-7 yr, and >7 yr correlated with poor TTF (5.6 mo vs 7.3, 8.0, 10.8, and 13.3 mo, p <  0.0001) and poor OS (median 16.7 mo vs 23.8, 30.2, 34.8, and 41.7 mo, p <  0.0001). In MVAs, the adjusted hazard ratios (95% confidence intervals) were 1.00 (reference), 0.98 (0.90-1.06), 0.81 (0.73-0.91), 0.74 (0.68-0.81), and 0.60 (0.54-0.67), respectively, for OS (p <  0.0001), and 1.00 (reference), 0.99 (0.92-1.06), 0.98 (0.90-1.07), 0.83 (0.77-0.89), and 0.66 (0.60-0.72), respectively, for TTF (p <  0.0001). Data were collected retrospectively. CONCLUSIONS: Timing of metastases after initial RCC diagnosis may impact the outcomes from targeted therapy in mRCC. PATIENT SUMMARY: We looked at the impact of the timing of metastatic outbreak on survival outcomes in kidney cancer patients treated with targeted therapy. We found that the longer time to metastatic development was associated with improved outcome.


Sujet(s)
Néphrocarcinome/mortalité , Néphrocarcinome/secondaire , Tumeurs du rein/mortalité , Tumeurs du rein/anatomopathologie , Sujet âgé , Bases de données factuelles , Femelle , Humains , Coopération internationale , Mâle , Adulte d'âge moyen , Études rétrospectives , Taux de survie , Facteurs temps
7.
Clin Genitourin Cancer ; 17(1): e32-e37, 2019 Feb.
Article de Anglais | MEDLINE | ID: mdl-30268423

RÉSUMÉ

BACKGROUND: Carcinoma of unknown primary site (CUP) is a heterogenous group of metastatic cancer with no detectable primary tumor site. Diagnostic assessment occasionally presents CUP with metastatic renal-cell carcinoma (mRCC) histologic and immunohistochemical characteristics (CUP-mRCC). Efficacy and toxicity data for vascular endothelial growth factor inhibitor therapies in CUP-mRCC patients are few. PATIENTS AND METHODS: We retrospectively reviewed consecutive patients with CUP-mRCC at a single institution between 2007 and 2018. Treatment outcomes were assessed from initiation of renal-cell carcinoma-specific therapy, including response rate, progression-free survival, and overall survival. RESULTS: Ten patients with CUP-mRCC were identified. Median age was 64 years. Histologies were clear-cell (30%), papillary type II (20%), and unclassified renal-cell (50%) carcinoma. International Metastatic Renal Cell Carcinoma Database Consortium risk group were favorable, intermediate, and poor in 0, 40%, and 60%, respectively. One patient received empiric first-line chemotherapy. Targeted treatments were pazopanib (n = 7), sunitinib (n = 2), and sorafenib (n = 1). Objective response rate was 40%, progression-free survival was 2.5 months (95% confidence interval, 1.2-3.8), and overall survival was 5.7 months (95% confidence interval, 0-24.0). Stratified for International Metastatic Renal Cell Carcinoma Database Consortium risk, overall survival in intermediate versus poor risk group were 18.6 months and 2.3 months, respectively. Second-line therapy did not result in disease control. No new or unexpected toxicities were observed. CONCLUSION: CUP-mRCC treated with vascular endothelial growth factor-targeted therapy is valid, feasible, and safe even though these patients had several negative prognostic factors. CUP-mRCC patients should be identified among CUP patients for specific renal-cell carcinoma therapy.


Sujet(s)
Carcinome papillaire/secondaire , Néphrocarcinome/secondaire , Tumeurs du rein/anatomopathologie , Thérapie moléculaire ciblée , Métastases d'origine inconnue/anatomopathologie , Inhibiteurs de protéines kinases/usage thérapeutique , Sujet âgé , Carcinome papillaire/traitement médicamenteux , Carcinome papillaire/métabolisme , Néphrocarcinome/traitement médicamenteux , Néphrocarcinome/métabolisme , Femelle , Études de suivi , Humains , Immunohistochimie , Tumeurs du rein/traitement médicamenteux , Tumeurs du rein/métabolisme , Métastase lymphatique , Mâle , Adulte d'âge moyen , Métastases d'origine inconnue/traitement médicamenteux , Métastases d'origine inconnue/métabolisme , Pronostic , Études rétrospectives , Taux de survie
8.
Curr Pharm Des ; 24(18): 1961-1965, 2018.
Article de Anglais | MEDLINE | ID: mdl-29766790

RÉSUMÉ

BACKGROUND: Vagal nerve plays an important role in the stomach function. The cholinergic nerves are the most abundantly distributed nerves in the gastric tissue. It has recently been reported that the vagal nerve is significantly related to both gastric cancer development and progression. However, its relation to the mesenchymal tumor, including MALT lymphoma, is not known. In this study, we investigated the effect of unilateral truncal vagotomy on gastric MALT lymphoma development by using Helicobacter heilmannii-infected mouse model as well as that of bilateral truncal vagotomy on stress-induced ulcer formation. METHODS: In the first part of this study, the distribution of the cholinergic nerves in the rat gastric mucosa and the effect of bilateral truncal vagotomy, as well as various kinds of agents acting on autonomic nerves in rats, were investigated by the histochemical and macroscopic method. In the second part, we employed MALT lymphoma formation in C57BL/6NCrl mice that were infected with Helicobacter heilmannii. A total of 38 infected mice underwent unilateral vagotomy under microscopy. The mice were randomized into 4 groups from which samples were collected; 2, 3, 4 and 6 months after infection. Both the anterior and posterior sides of the stomachs were sampled from each mouse for pathological and immunohistochemical analyses. RESULTS: The bilateral truncal vagotomy significantly suppressed the restraint-induced gastric ulcer formation in rats, while bethanechol, and 6-hydroxydopamine led to an increase of the gastric ulcer formation. In the unilateral truncal vagotomy study using MALT lymphoma, the thickness of the gastric mucosa was reduced in the vagotomized side compared to the non-vagotomized side. Furthermore, the gastric MALT lymphoma was more prominently found in the vagotomized anterior side of stomach compared with that in the non-vagotomized posterior side of stomach. Substance P-immunoreactive nerves markedly increased surrounding the MALT lymphoma and the neurokinin-1 receptor immunoreactive lymphocytes increased within the MALT lymphoma in the vagotomized side. In conclusion, vagotomy enhanced gastric MALT lymphoma development possibly through the substance P-neurokinin-1 receptor pathway.


Sujet(s)
Neurones cholinergiques/métabolisme , Lymphome B de la zone marginale/métabolisme , Ulcère gastrique/métabolisme , Substance P/métabolisme , Vagotomie tronculaire , Animaux , Béthanéchol/pharmacologie , Neurones cholinergiques/effets des médicaments et des substances chimiques , Humains , Lymphome B de la zone marginale/traitement médicamenteux , Lymphome B de la zone marginale/chirurgie , Oxidopamine/pharmacologie , Ulcère gastrique/traitement médicamenteux , Ulcère gastrique/chirurgie , Stress physiologique/effets des médicaments et des substances chimiques
9.
ISME J ; 12(1): 77-86, 2018 01.
Article de Anglais | MEDLINE | ID: mdl-28885626

RÉSUMÉ

Helicobacter suis is the second most prevalent Helicobacter species in the stomach of humans suffering from gastric disease. This bacterium mainly inhabits the stomach of domesticated pigs, in which it causes gastric disease, but it appears to be absent in wild boars. Interestingly, it also colonizes the stomach of asymptomatic rhesus and cynomolgus monkeys. The origin of modern human-, pig- or non-human primate-associated H. suis strains in these respective host populations was hitherto unknown. Here we show that H. suis in pigs possibly originates from non-human primates. Our data suggest that a host jump from macaques to pigs happened between 100 000 and 15 000 years ago and that pig domestication has had a significant impact on the spread of H. suis in the pig population, from where this pathogen occasionally infects humans. Thus, in contrast to our expectations, H. suis appears to have evolved in its main host in a completely different way than its close relative Helicobacter pylori in humans.


Sujet(s)
Infections à Helicobacter/microbiologie , Infections à Helicobacter/médecine vétérinaire , Helicobacter heilmannii/isolement et purification , Macaca fascicularis/microbiologie , Macaca mulatta/microbiologie , Maladies des porcs/microbiologie , Animaux , Animaux domestiques/microbiologie , Helicobacter heilmannii/classification , Helicobacter heilmannii/génétique , Helicobacter heilmannii/croissance et développement , Humains , Phylogenèse , Estomac/microbiologie , Suidae
10.
Curr Pharm Des ; 23(27): 3993-3996, 2017 10 30.
Article de Anglais | MEDLINE | ID: mdl-28190393

RÉSUMÉ

Backgound: The role of enteric nerves has previously been demonstrated in the formation of several gastric diseases. In the present review, the significance of the cholinergic nerves in stress-induced ulcer formation as well as the importance of substance P in the formation of gastric MALT lymphoma is discussed. METHODS: The stress-induced ulcer was induced by the plaster bandage methods in rats. The gastric MALT lymphoma was formed by the peroral infection of gastric mucosal homogenate of the infected mouse in C57BL/6 mice. For the stress-induced ulcer, the distribution of the cholinergic nerves and muscarinic acetylcholine receptors was investigated by acetylcholinesterase histochemistry and autoradiography of water soluble compounds using 3H-quinuclidinyl benzilate was performed. To the MALT lymphoma study, the distribution of the substance P and effect of substance P antagonist, spantide II, was investigated by immunohistochemical studies. RESULTS: The stress induced ulcer formation was shown to be related to the hyperactivity of the cholinergic nerves. The gastric MALT lymphoma was shown to be related to the increased localization of substance P. CONCLUSION: Stress-induced ulceration as a model of hyperactivity of the cholinergic nerves was proved to be a useful approach, while substance P and its role in MALT lymphoma formation may serve as a tool to clarify the neuroimmune modulation of chronic infectious diseases.


Sujet(s)
Ganglions du système nerveux autonome/physiologie , Lymphome B de la zone marginale/étiologie , Tumeurs de l'estomac/étiologie , Ulcère gastrique/étiologie , Estomac/innervation , Acetylcholinesterase/pharmacologie , Animaux , Neurones cholinergiques/effets des médicaments et des substances chimiques , Neurones cholinergiques/ultrastructure , Ganglions du système nerveux autonome/ultrastructure , Lymphome B de la zone marginale/ultrastructure , Souris , Souris de lignée C57BL , Rats , Tumeurs de l'estomac/ultrastructure , Stress physiologique , Substance P/pharmacologie
11.
Digestion ; 95(1): 61-66, 2017.
Article de Anglais | MEDLINE | ID: mdl-28052279

RÉSUMÉ

BACKGROUND: Non-Helicobacter pylori-helicobacters (NHPH) compose a group of gram negative zoonotic bacteria that may induce in humans gastric diseases including gastritis, gastroduodenal ulcer and MALT lymphoma. Their prevalence in the general population has previously been reported to 0.1-6.2%, although such reports still remain less in number. AIMS: This study aimed at estimating the prevalence of gastric NHPH in Japanese people, and further aimed at linking this to different gastric diseases and co-infection with H. pylori. METHODS: Endoscopically obtained biopsy samples from 280 Japanese patients with various gastric diseases were collected. Samples were analyzed by immunohistochemistry and by species-specific PCR for detection of gastric helicobacters. RESULTS: The total prevalence of gastric NHPH among 280 Japanese patients was 6.1%, and the prevalence of H. pylori was 65.7%. There was no significant difference in prevalence of either NHPH or H. pylori when infected with H. pylori or NHPH, respectively. NHPH infection was found to be the highest in patients with gastric MALT lymphoma and duodenal ulcer, the former being independent of co-infection with H. pylori and the latter being dependent. CONCLUSIONS: This study reports a total prevalence of 6.1% of gastric NHPH in Japanese patients, and further highlights gastric MALT lymphoma and duodenal ulcer (when co-infected with H. pylori) as important related diseases.


Sujet(s)
Infections à Helicobacter/épidémiologie , Helicobacter , Maladies de l'estomac/microbiologie , Adolescent , Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Ulcère duodénal/épidémiologie , Ulcère duodénal/microbiologie , Femelle , Muqueuse gastrique/microbiologie , Muqueuse gastrique/anatomopathologie , Infections à Helicobacter/microbiologie , Humains , Immunohistochimie , Japon/épidémiologie , Lymphome B de la zone marginale/épidémiologie , Lymphome B de la zone marginale/microbiologie , Mâle , Adulte d'âge moyen , Réaction de polymérisation en chaîne , Prévalence , Maladies de l'estomac/épidémiologie , Maladies de l'estomac/anatomopathologie , Jeune adulte
12.
Genome Announc ; 4(5)2016 Sep 08.
Article de Anglais | MEDLINE | ID: mdl-27609915

RÉSUMÉ

We present here the draft whole-genome shotgun sequence of an uncultivated strain SNTW101 of Helicobacter suis, which has been maintained in the stomachs of mice. This strain was originally isolated from gastric biopsy specimens of a urea breath test-negative Japanese patient suffering from nodular gastritis.

13.
BMC Genomics ; 17(1): 740, 2016 09 17.
Article de Anglais | MEDLINE | ID: mdl-27639974

RÉSUMÉ

BACKGROUND: Isothiocyanates (ITCs) are degradation products of the plant secondary metabolites glucosinolates (GSLs) and are known to affect human health as well as plant herbivores and pathogens. To investigate the processes engaged in plants upon exposure to isothiocyanate we performed a genome scale transcriptional profiling of Arabidopsis thaliana at different time points in response to an exogenous treatment with allyl-isothiocyanate. RESULTS: The treatment triggered a substantial response with the expression of 431 genes affected (P < 0.05 and log2 ≥ 1 or ≤ -1) already after 30 min and that of 3915 genes affected after 9 h of exposure, most of the affected genes being upregulated. These are involved in a considerable number of different biological processes, some of which are described in detail: glucosinolate metabolism, sulphate uptake and assimilation, heat stress response, oxidative stress response, elicitor perception, plant defence and cell death mechanisms. CONCLUSION: Exposure of Arabidopsis thaliana to vapours of allyl-isothiocyanate triggered a rapid and substantial transcriptional response affecting numerous biological processes. These include multiple stress stimuli such as heat stress response and oxidative stress response, cell death and sulphur secondary defence metabolism. Hence, effects of isothiocyanates on plants previously reported in the literature were found to be regulated at the gene expression level. This opens some avenues for further investigations to decipher the molecular mechanisms underlying the effects of isothiocyanates on plants.


Sujet(s)
Arabidopsis/effets des médicaments et des substances chimiques , Arabidopsis/génétique , Régulation de l'expression des gènes végétaux/effets des médicaments et des substances chimiques , Réaction de choc thermique/génétique , Isothiocyanates/pharmacologie , Stress oxydatif/génétique , Biologie informatique/méthodes , Analyse de profil d'expression de gènes , Gene Ontology , Glucosinolates/métabolisme , Glutathion/métabolisme , Homéostasie , Voies et réseaux métaboliques , Annotation de séquence moléculaire , Récepteurs de reconnaissance de motifs moléculaires/métabolisme , Transcription génétique
14.
J Infect Chemother ; 22(9): 587-92, 2016 Sep.
Article de Anglais | MEDLINE | ID: mdl-27346378

RÉSUMÉ

We aimed to identify narrow-spectrum natural compounds that specifically inhibit an alternative menaquinone (MK; vitamin K2) biosynthetic pathway (the futalosine pathway) of Helicobacter pylori. Culture broth samples of 6183 microbes were examined using the paper disc method with different combinations of 2 of the following 3 indicator microorganisms: Bacillus halodurans C-125 and Kitasatospora setae KM-6054(T), which have only the futalosine pathway of MK biosynthesis, and Bacillus subtilis H17, which has only the canonical MK biosynthetic pathway. Most of the active compounds isolated from culture broth samples were from the families of polyunsaturated fatty acids (PUFAs). Only one compound isolated from the culture broth of Streptomyces sp. K12-1112, siamycin I (a 21-residue lasso peptide antibiotic), targeted the futalosine pathway. The inhibitory activities of representative PUFAs and siamycin I against the growth of B. halodurans or K. setae were abrogated by supplementation with MK. Thereafter, the growth of H. pylori strains SS1 and TN2GF4 in broth cultures was dose-dependently suppressed by eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), or siamycin I, and these inhibitory effects were reduced by supplementation with MK. Daily administration of EPA (100 µM), DHA (100 µM), or siamycin I (2.5 µM) in drinking water reduced the H. pylori SS1 colonization in the gastric mucosa of C57BL/6 mice by 96%, 78%, and 68%, respectively. These data suggest that EPA, DHA, and siamycin I prevented H. pylori infection by inhibiting the futalosine pathway of MK biosynthesis.


Sujet(s)
Voies de biosynthèse/effets des médicaments et des substances chimiques , Résistance bactérienne aux médicaments/effets des médicaments et des substances chimiques , Infections à Helicobacter/prévention et contrôle , Helicobacter pylori/effets des médicaments et des substances chimiques , Nucléosides/biosynthèse , Vitamine K2/pharmacologie , Animaux , Acide docosahexaénoïque/antagonistes et inhibiteurs , Acide docosahexaénoïque/pharmacologie , Association de médicaments , Acide eicosapentanoïque/antagonistes et inhibiteurs , Acide eicosapentanoïque/pharmacologie , Femelle , Infections à Helicobacter/traitement médicamenteux , Helicobacter pylori/croissance et développement , Helicobacter pylori/isolement et purification , Helicobacter pylori/métabolisme , Protéines et peptides de signalisation intercellulaire , Souris , Souris de lignée C57BL , Peptides/antagonistes et inhibiteurs , Peptides/pharmacologie
15.
Digestion ; 93(4): 260-5, 2016.
Article de Anglais | MEDLINE | ID: mdl-27160882

RÉSUMÉ

Non-Helicobacter pylori-Helicobacters including H. suis, H. heilmanniisensu stricto and H. felis comprise a group of bacteria that may inhabit the stomach of humans and animals. Human gastric infection has been associated with gastritis, ulcer, MALT lymphoma and cancer. Although the fastidious nature of these organisms has hampered their research, recent advancements in in vitro cultivation and recent reports on in vivo models and prevalence studies in humans suggest this group of bacteria to be of more clinical significance than earlier believed. The present review discusses their history, microbiology and relevance to human health.


Sujet(s)
Muqueuse gastrique/microbiologie , Gastrite/microbiologie , Infections à Helicobacter , Helicobacter , Lymphome malin non hodgkinien/microbiologie , Tumeurs de l'estomac/microbiologie , Estomac/microbiologie , Animaux , Muqueuse gastrique/anatomopathologie , Helicobacter/classification , Helicobacter/génétique , Helicobacter/isolement et purification , Infections à Helicobacter/épidémiologie , Infections à Helicobacter/immunologie , Infections à Helicobacter/microbiologie , Humains , Phylogenèse
16.
J Infect Chemother ; 22(4): 229-34, 2016 Apr.
Article de Anglais | MEDLINE | ID: mdl-26908231

RÉSUMÉ

The Streptococcus dysgalactiae subspecies equisimilis (SDSE) possesses clinical similarities to group A streptococcus (GAS) and has recently been recognized as a causative pathogen of life-threatening streptococcal infections. Human membrane cofactor protein (CD46), a complement regulatory protein ubiquitously expressed on every cell type except for erythrocytes, has been implicated as a receptor for human-specific pathogens including GAS. In the present report, SDSE strain GGS_124 was isolated from a patient suffering from streptococcal toxic shock syndrome. When CD46-expressing transgenic (Tg) and non-Tg mice were infected subcutaneously into a hind footpad with 1 × 10(7) colony-forming units of GGS_124, both CD46 Tg and non-Tg mice showed similar levels of colonization in the popliteal lymph nodes at day 3 after infection. However, the following differences were found between CD46 Tg and non-Tg mice after infection. First, there was a statistically significant difference in mortality rates between CD46 Tg (33%) and non-Tg (0%) mice within 35 days after infection. Second, all surviving CD46 Tg mice developed ankle arthritis at day 35 after infection, whereas non-Tg mice did not develop ankle arthritis on the infected hind paws. Finally, CD46 Tg mice developed a pus-filled abscess accompanied by renal failure at day 6 or later after infection. These observations suggest that CD46, the host cell-surface pathogen receptor, functioned to attract GGS_124 into deep tissues, so that the subcutaneous infection with GGS_124 induced invasive streptococcal diseases in CD46 Tg mice.


Sujet(s)
Arthrite infectieuse/microbiologie , Antigènes CD46/génétique , Choc septique/microbiologie , Infections à streptocoques/microbiologie , Animaux , Arthrite infectieuse/immunologie , Modèles animaux de maladie humaine , Prédisposition aux maladies/immunologie , Humains , Injections sous-cutanées , Mâle , Antigènes CD46/administration et posologie , Antigènes CD46/immunologie , Souris , Souris de lignée C57BL , Souris transgéniques , Choc septique/immunologie , Infections à streptocoques/immunologie , Streptococcus
17.
Cell Microbiol ; 18(10): 1390-404, 2016 10.
Article de Anglais | MEDLINE | ID: mdl-26894505

RÉSUMÉ

Human CD46 is a receptor for the M protein of group A streptococcus (GAS). The emm1 GAS strain GAS472 was isolated from a patient suffering from streptococcal toxic shock-like syndrome. Human CD46-expressing transgenic (Tg) mice developed necrotizing fasciitis associated with osteoclast-mediated progressive and severe bone destruction in the hind paws 3 days after subcutaneous infection with 5 × 10(5) colony-forming units of GAS472. GAS472 infection induced expression of the receptor activator of nuclear factor-κB ligand (RANKL) while concomitantly reducing osteoprotegerin expression in the hind limb bones of CD46 Tg mice. Micro-computed tomography analysis of the bones suggested that GAS472 infection induced local bone erosion and systemic bone loss in CD46 Tg mice. Because treatment with monoclonal antibodies (mAbs) against mouse CD4(+) and CD8(+) T lymphocytes did not inhibit osteoclastogenesis, T lymphocyte-derived RANKL was not considered a major contributor to massive bone loss during GAS472 infection. However, immunohistochemical analysis of the hind limb bones showed that GAS472 infection stimulated RANKL production in various bone marrow cells, including fibroblast-like cells. Treatment with a mAb against mouse RANKL significantly inhibited osteoclast formation and bone resorption. These data suggest that increased expression of RANKL in heterogeneous bone marrow cells provoked bone destruction during GAS infection.


Sujet(s)
Ligand de RANK/génétique , Infections à streptocoques/génétique , Streptococcus pyogenes/immunologie , Activation de la transcription/immunologie , Animaux , Résorption osseuse/immunologie , Résorption osseuse/microbiologie , Expression des gènes , Membre pelvien/microbiologie , Membre pelvien/anatomopathologie , Humains , Mâle , Antigènes CD46/génétique , Antigènes CD46/métabolisme , Souris de lignée C57BL , Souris transgéniques , Ostéocytes/métabolisme , Ostéoprotégérine/génétique , Ostéoprotégérine/métabolisme , Ligand de RANK/métabolisme , Infections à streptocoques/immunologie , Infections à streptocoques/métabolisme , Tibia/microbiologie , Tibia/anatomopathologie
18.
Int J Mol Sci ; 16(12): 29134-47, 2015 Dec 07.
Article de Anglais | MEDLINE | ID: mdl-26690132

RÉSUMÉ

Volatile allyl isothiocyanate (AITC) derives from the biodegradation of the glucosinolate sinigrin and has been associated with growth inhibition in several plants, including the model plant Arabidopsis thaliana. However, the underlying cellular mechanisms of this feature remain scarcely investigated in plants. In this study, we present evidence of an AITC-induced inhibition of actin-dependent intracellular transport in A. thaliana. A transgenic line of A. thaliana expressing yellow fluorescent protein (YFP)-tagged actin filaments was used to show attenuation of actin filament movement by AITC. This appeared gradually in a time- and dose-dependent manner and resulted in actin filaments appearing close to static. Further, we employed four transgenic lines with YFP-fusion proteins labeling the Golgi apparatus, endoplasmic reticulum (ER), vacuoles and peroxisomes to demonstrate an AITC-induced inhibition of actin-dependent intracellular transport of or, in these structures, consistent with the decline in actin filament movement. Furthermore, the morphologies of actin filaments, ER and vacuoles appeared aberrant following AITC-exposure. However, AITC-treated seedlings of all transgenic lines tested displayed morphologies and intracellular movements similar to that of the corresponding untreated and control-treated plants, following overnight incubation in an AITC-absent environment, indicating that AITC-induced decline in actin-related movements is a reversible process. These findings provide novel insights into the cellular events in plant cells following exposure to AITC, which may further expose clues to the physiological significance of the glucosinolate-myrosinase system.


Sujet(s)
Actines/métabolisme , Arabidopsis/métabolisme , Isothiocyanates/métabolisme , Protéines végétales/métabolisme , Cytosquelette d'actine/métabolisme , Cytosquelette d'actine/ultrastructure , Actines/ultrastructure , Arabidopsis/cytologie , Transport biologique , Protéines végétales/ultrastructure
19.
Front Plant Sci ; 6: 364, 2015.
Article de Anglais | MEDLINE | ID: mdl-26042144

RÉSUMÉ

Isothiocyanates (ITCs) are degradation products of glucosinolates present in members of the Brassicaceae family acting as herbivore repellents and antimicrobial compounds. Recent results indicate that allyl ITC (AITC) has a role in defense responses such as glutathione depletion, ROS generation and stomatal closure. In this study we show that exposure to non-lethal concentrations of AITC causes a shift in the cell cycle distribution of Arabidopsis thaliana leading to accumulation of cells in S-phases and a reduced number of cells in non-replicating phases. Furthermore, transcriptional analysis revealed an AITC-induced up-regulation of the gene encoding cyclin-dependent kinase A while several genes encoding mitotic proteins were down-regulated, suggesting an inhibition of mitotic processes. Interestingly, visualization of DNA synthesis indicated that exposure to AITC reduced the rate of DNA replication. Taken together, these results indicate that non-lethal concentrations of AITC induce cells of A. thaliana to enter the cell cycle and accumulate in S-phases, presumably as a part of a defensive response. Thus, this study suggests that AITC has several roles in plant defense and add evidence to the growing data supporting a multifunctional role of glucosinolates and their degradation products in plants.

20.
Front Plant Sci ; 6: 277, 2015.
Article de Anglais | MEDLINE | ID: mdl-25954298

RÉSUMÉ

Allyl isothiocyanate (AITC) is a phytochemical associated with plant defense in plants from the Brassicaceae family. AITC has long been recognized as a countermeasure against external threats, but recent reports suggest that AITC is also involved in the onset of defense-related mechanisms such as the regulation of stomatal aperture. However, the underlying cellular modes of action in plants remain scarcely investigated. Here we report evidence of an AITC-induced depletion of glutathione (GSH) and the effect on gene expression of the detoxification enzyme family glutathione S-transferases (GSTs) in Arabidopsis thaliana. Treatment of A. thaliana wild-type with AITC resulted in a time- and dose-dependent depletion of cellular GSH. AITC-exposure of mutant lines vtc1 and pad2-1 with elevated and reduced GSH-levels, displayed enhanced and decreased AITC-tolerance, respectively. AITC-exposure also led to increased ROS-levels in the roots and loss of chlorophyll which are symptoms of oxidative stress. Following exposure to AITC, we found that GSH rapidly recovered to the same level as in the control plant, suggesting an effective route for replenishment of GSH or a rapid detoxification of AITC. Transcriptional analysis of genes encoding GSTs showed an upregulation in response to AITC. These findings demonstrate cellular effects by AITC involving a reversible depletion of the GSH-pool, induced oxidative stress, and elevated expression of GST-encoding genes.

SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...